|
KIF5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.550600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.850400E-01 |
| Normal-vs-Stage2 |
1.481020E-01 |
| Normal-vs-Stage3 |
6.588500E-02 |
| Normal-vs-Stage4 |
1.526600E-01 |
| Stage1-vs-Stage2 |
3.156200E-01 |
| Stage1-vs-Stage3 |
1.099240E-01 |
| Stage1-vs-Stage4 |
3.110400E-01 |
| Stage2-vs-Stage3 |
8.701400E-01 |
| Stage2-vs-Stage4 |
9.927200E-01 |
| Stage3-vs-Stage4 |
8.605800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.747230E-01 |
| Normal-vs-AfricanAmerican |
5.705600E-01 |
| Normal-vs-Asian |
3.159600E-01 |
| Caucasian-vs-AfricanAmerican |
1.248830E-01 |
| Caucasian-vs-Asian |
9.139200E-01 |
| AfricanAmerican-vs-Asian |
2.124800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.773900E-02 |
| Normal-vs-Female |
4.164400E-01 |
| Male-vs-Female |
3.517800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.542600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.808400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.019200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.840800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.588380E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.943570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.180400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.578000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.913000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.853800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.823000E-01 |
| Classical-VS-Follicular |
7.966300E-02 |
| Classical-VS-Other |
1.080810E-01 |
| Classical-VS-Normal |
6.685200E-01 |
| Tall-VS-Follicular |
8.022000E-01 |
| Tall-VS-Other |
2.036000E-01 |
| Tall-VS-Normal |
2.424600E-01 |
| Follicular-VS-Other |
3.313200E-01 |
| Follicular-VS-Normal |
1.059980E-01 |
| Other-VS-Normal |
5.086400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.036400E-02 |
| Normal-vs-N1 |
1.529360E-01 |
| N0-vs-N1 |
9.463400E-01 |
|
|
